China Payables Turnover vs Free Cash Flow Per Share Analysis

SXTC Stock  USD 0.43  0.05  10.42%   
China SXT financial indicator trend analysis is way more than just evaluating China SXT Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether China SXT Pharmaceuticals is a good investment. Please check the relationship between China SXT Payables Turnover and its Free Cash Flow Per Share accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in China SXT Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Payables Turnover vs Free Cash Flow Per Share

Payables Turnover vs Free Cash Flow Per Share Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of China SXT Pharmaceuticals Payables Turnover account and Free Cash Flow Per Share. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between China SXT's Payables Turnover and Free Cash Flow Per Share is -0.1. Overlapping area represents the amount of variation of Payables Turnover that can explain the historical movement of Free Cash Flow Per Share in the same time period over historical financial statements of China SXT Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of China SXT's Payables Turnover and Free Cash Flow Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Payables Turnover of China SXT Pharmaceuticals are associated (or correlated) with its Free Cash Flow Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Per Share has no effect on the direction of Payables Turnover i.e., China SXT's Payables Turnover and Free Cash Flow Per Share go up and down completely randomly.

Correlation Coefficient

-0.1
Relationship DirectionNegative 
Relationship StrengthInsignificant

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Free Cash Flow Per Share

The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.
Most indicators from China SXT's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into China SXT Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in China SXT Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
At present, China SXT's Enterprise Value Over EBITDA is projected to increase slightly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 6.50, whereas Tax Provision is forecasted to decline to 0.00.
 2021 2022 2023 2024 (projected)
Gross Profit1.3M426.3K554.0K526.3K
Total Revenue2.6M2.0M1.9M3.5M

China SXT fundamental ratios Correlations

0.90.960.980.91-0.74-0.760.970.970.410.89-0.780.550.930.960.980.47-0.260.330.830.50.71-0.83-0.930.940.88
0.90.940.830.73-0.55-0.590.820.820.360.67-0.560.810.740.930.860.13-0.160.110.590.150.6-0.63-0.870.890.85
0.960.940.870.79-0.67-0.60.870.870.460.77-0.630.70.841.00.940.46-0.240.180.680.480.66-0.66-0.830.890.85
0.980.830.870.95-0.75-0.830.980.980.370.94-0.840.420.940.880.950.45-0.250.410.890.480.71-0.91-0.940.920.86
0.910.730.790.95-0.87-0.840.930.930.190.96-0.840.240.930.80.880.45-0.380.660.850.490.58-0.88-0.920.890.84
-0.74-0.55-0.67-0.75-0.870.67-0.79-0.790.12-0.780.68-0.12-0.89-0.68-0.66-0.50.74-0.79-0.58-0.55-0.20.610.75-0.83-0.85
-0.76-0.59-0.6-0.83-0.840.67-0.79-0.79-0.29-0.80.96-0.11-0.78-0.61-0.73-0.370.27-0.49-0.75-0.41-0.530.760.77-0.73-0.69
0.970.820.870.980.93-0.79-0.791.00.260.91-0.820.40.960.880.930.47-0.340.390.820.510.64-0.87-0.960.930.88
0.970.820.870.980.93-0.79-0.791.00.260.91-0.820.40.960.880.930.47-0.340.390.820.510.64-0.87-0.960.930.88
0.410.360.460.370.190.12-0.290.260.260.34-0.350.370.190.450.540.480.51-0.350.530.440.76-0.32-0.120.150.04
0.890.670.770.940.96-0.78-0.80.910.910.34-0.830.190.880.770.910.57-0.260.580.890.60.66-0.89-0.860.790.72
-0.78-0.56-0.63-0.84-0.840.680.96-0.82-0.82-0.35-0.83-0.04-0.81-0.64-0.77-0.530.22-0.46-0.82-0.57-0.620.790.75-0.72-0.65
0.550.810.70.420.24-0.12-0.110.40.40.370.19-0.040.330.690.51-0.130.01-0.310.16-0.150.34-0.17-0.460.560.56
0.930.740.840.940.93-0.89-0.780.960.960.190.88-0.810.330.850.860.55-0.530.520.780.590.49-0.79-0.880.940.92
0.960.931.00.880.8-0.68-0.610.880.880.450.77-0.640.690.850.940.47-0.260.20.690.480.65-0.67-0.830.90.86
0.980.860.940.950.88-0.66-0.730.930.930.540.91-0.770.510.860.940.56-0.120.260.860.570.8-0.84-0.870.850.77
0.470.130.460.450.45-0.5-0.370.470.470.480.57-0.53-0.130.550.470.56-0.210.240.551.00.45-0.41-0.220.290.25
-0.26-0.16-0.24-0.25-0.380.740.27-0.34-0.340.51-0.260.220.01-0.53-0.26-0.12-0.21-0.630.05-0.240.470.00.32-0.46-0.58
0.330.110.180.410.66-0.79-0.490.390.39-0.350.58-0.46-0.310.520.20.260.24-0.630.380.29-0.08-0.41-0.430.430.46
0.830.590.680.890.85-0.58-0.750.820.820.530.89-0.820.160.780.690.860.550.050.380.580.85-0.94-0.740.70.59
0.50.150.480.480.49-0.55-0.410.510.510.440.6-0.57-0.150.590.480.571.0-0.240.290.580.44-0.45-0.260.330.29
0.710.60.660.710.58-0.2-0.530.640.640.760.66-0.620.340.490.650.80.450.47-0.080.850.44-0.79-0.570.490.34
-0.83-0.63-0.66-0.91-0.880.610.76-0.87-0.87-0.32-0.890.79-0.17-0.79-0.67-0.84-0.410.0-0.41-0.94-0.45-0.790.85-0.74-0.64
-0.93-0.87-0.83-0.94-0.920.750.77-0.96-0.96-0.12-0.860.75-0.46-0.88-0.83-0.87-0.220.32-0.43-0.74-0.26-0.570.85-0.94-0.9
0.940.890.890.920.89-0.83-0.730.930.930.150.79-0.720.560.940.90.850.29-0.460.430.70.330.49-0.74-0.940.99
0.880.850.850.860.84-0.85-0.690.880.880.040.72-0.650.560.920.860.770.25-0.580.460.590.290.34-0.64-0.90.99
Click cells to compare fundamentals

China SXT Account Relationship Matchups

China SXT fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets21.7M34.5M33.5M29.6M23.1M21.9M
Other Current Liab3.3M15.7M12.3M8.5M4.0M6.5M
Total Current Liabilities12.3M18.6M17.1M14.5M8.9M11.1M
Total Stockholder Equity9.4M16.0M16.4M14.7M13.9M10.7M
Net Tangible Assets11.0M9.4M15.9M16.4M18.8M19.8M
Retained Earnings(7.2M)(10.0M)(15.7M)(21.6M)(24.7M)(23.5M)
Accounts Payable1.9M1.5M1.5M1.4M1.3M1.4M
Cash7.3M13.3M15.5M17.4M12.1M9.2M
Cash And Short Term Investments7.3M13.3M15.5M17.4M12.1M9.2M
Net Receivables10.6M7.8M4.9M1.3M1.3M1.3M
Inventory892.8K859.7K1.0M531.3K809.8K799.6K
Other Current Assets144.3K1.3M995.8K230.6K6.8K6.5K
Other Stockholder Equity17.2M25.3M31.0M35.6M35.3M19.0M
Total Liab12.3M18.6M17.1M14.9M9.2M11.2M
Total Current Assets19.6M23.2M22.5M19.5M14.2M16.1M
Short Term Debt6.7M37.1K2.0M3.4M2.4M1.9M
Intangible Assets50.1K45.8K38.8K27.9K19.1K34.3K
Common Stock34.7K62.1K162.5K913.8K4.4M4.6M
Property Plant Equipment1.8M1.9M1.8M1.6M1.8M1.5M
Short Long Term Debt Total6.7M43.4K2.0M3.8M2.6M2.2M
Property Plant And Equipment Net1.9M1.8M1.6M1.3M564.7K1.1M
Current Deferred Revenue298.0K257.4K77.4K165.5K187.7K192.3K
Net Debt(563.2K)(13.3M)(13.5M)(13.6M)(9.4M)(9.9M)
Non Current Assets Total2.1M11.3M11.1M10.0M8.9M6.5M
Non Currrent Assets Other441.2K9.2M9.5M8.7M8.3M5.0M
Common Stock Shares Outstanding12.4K28.8K41.6K267.0K867.4K910.8K
Liabilities And Stockholders Equity21.7M34.5M33.5M29.6M23.1M23.8M
Non Current Liabilities Total36.5K6.3K3.6M365.8K294.7K279.9K
Property Plant And Equipment Gross1.9M1.8M3.4M3.2M3.1M2.4M
Short Long Term Debt6.7M37.1K2.0M3.3M2.3M2.1M
Accumulated Other Comprehensive Income(590.7K)527.8K956.1K(197.6K)(1.0M)(974.5K)
Other Assets13.5K112.8K9.5M9.5M10.9M11.4M
Net Invested Capital16.1M16.0M18.5M18.1M16.3M15.7M
Net Working Capital7.4M4.7M5.3M5.0M5.3M6.1M
Capital Stock34.7K62.1K162.5K913.8K4.4M4.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether China SXT Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of China SXT's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of China Sxt Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on China Sxt Pharmaceuticals Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in China SXT Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China SXT. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China SXT listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.426
Earnings Share
(3.57)
Revenue Per Share
2.223
Quarterly Revenue Growth
0.295
Return On Assets
(0.05)
The market value of China SXT Pharmaceuticals is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China SXT's value that differs from its market value or its book value, called intrinsic value, which is China SXT's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China SXT's market value can be influenced by many factors that don't directly affect China SXT's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China SXT's value and its price as these two are different measures arrived at by different means. Investors typically determine if China SXT is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China SXT's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.